Evidence map›Paper›PMID 35803222›Full record

ArticleCell stem cell2022

Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1.

Antal Rot, Julia C Gutjahr, Aindrila Biswas, Maria Aslani, Elin Hub, Aude Thiriot, Ulrich H von Andrian, Remco T A Megens, Christian Weber, Johan Duchene

Open access · greenAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Cell stem cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Atypical chemokine receptors in the immune system.Nature reviews. Immunology · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Antal RotCentre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; Centre for Inflammation and Therapeutic Innovation, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK; Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany. Electronic address: a.rot@qmul.ac.uk.
Julia C GutjahrCentre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Aindrila BiswasInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany.
Maria AslaniInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany.
Elin HubCentre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK; Centre for Inflammation and Therapeutic Innovation, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK.
Aude ThiriotDepartment of Immunology & HMS Center for Immune Imaging, Harvard Medical School, Boston, MA 02115, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA USA.
Ulrich H von AndrianDepartment of Immunology & HMS Center for Immune Imaging, Harvard Medical School, Boston, MA 02115, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA USA.
Remco T A MegensInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany; Cardiovascular Research Institute Maastricht, University of Maastricht, P. Debeyelaan, 6229HX Maastricht, the Netherlands.
Christian WeberInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany; Cardiovascular Research Institute Maastricht, University of Maastricht, P. Debeyelaan, 6229HX Maastricht, the Netherlands; German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Pettenkoferstrasse 8a & 9, 80336 Munich, Germany.
Johan DucheneInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany; German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Pettenkoferstrasse 8a & 9, 80336 Munich, Germany. Electronic address: johan.duchene@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DEHarvard University · USMunich Cluster for Systems Neurology · DEQueen Mary University of London · GBRagon Institute of MGH, MIT and Harvard · USWilliam Harvey Research Institute · GB

Funding

European Research Council 692511Wellcome Trust 200817/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone MarrowMonocytesAnimalsBone Marrow CellsHumansMacrophagesMiceReceptors, ChemokineReceptors, Chemokine

Identifiers

PMID35803222
OpenAlexW4284888485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.